| MeSH term | MeSH ID | Detail |
|---|---|---|
| Coronary Disease | D003327 | 70 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Mitochondrial Diseases | D028361 | 25 associated lipids |
Total
3
Palmitoylcarnitine
Palmitoylcarnitine is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1026 references associated with Palmitoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Palmitoylcarnitine
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Palmitoylcarnitine
NCBI Entrez Crosslinks
All references with Palmitoylcarnitine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhang XJ et al. | Measurement of precursor enrichment for calculating intramuscular triglyceride fractional synthetic rate. | 2012 | J. Lipid Res. | pmid:21934122 |
| Shi X et al. | Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity. | 2012 | J. Lipid Res. | pmid:22904346 |
| Arduini A et al. | High performance liquid chromatography of long-chain acylcarnitine and phospholipids in fatty acid turnover studies. | 1996 | J. Lipid Res. | pmid:8728329 |
| Clarke B et al. | On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea-pig heart. | 1996 | J. Mol. Cell. Cardiol. | pmid:8745225 |
| Netticadan T et al. | Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes. | 1999 | J. Mol. Cell. Cardiol. | pmid:10403753 |
| Williams ES and Li TK | The effect of chronic alcohol administration on fatty acid metabolism and pyruvate oxidation of heart mitochondria. | 1977 | J. Mol. Cell. Cardiol. | pmid:563474 |
| Fantini E et al. | Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. | 1994 | J. Mol. Cell. Cardiol. | pmid:7799450 |
| Wenzel U et al. | Increased carnitine-dependent fatty acid uptake into mitochondria of human colon cancer cells induces apoptosis. | 2005 | J. Nutr. | pmid:15930461 |
| Schmidt I and Herpin P | Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs. | 1998 | J. Nutr. | pmid:9566999 |
| Hara A et al. | Protective effects of dilazep and its derivative K-7259 on the haemolysis induced by amphiphiles in rat erythrocytes. | 1997 | J. Pharm. Pharmacol. | pmid:9379361 |
| Bergstrand H et al. | Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor. | 1992 | J. Pharmacol. Exp. Ther. | pmid:1372047 |
| Wu Y et al. | The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction. | 2009 | J. Pharmacol. Exp. Ther. | pmid:19403851 |
| Duizer E et al. | Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. | 1998 | J. Pharmacol. Exp. Ther. | pmid:9765361 |
| Muraki K and Imaizumi Y | A novel action of palmitoyl-L-carnitine in human vascular endothelial cells. | 2003 | J. Pharmacol. Sci. | pmid:12890891 |
| Dumonteil E et al. | Effects of palmitoyl carnitine and related metabolites on the avian Ca(2+)-ATPase and Ca2+ release channel. | 1994 | J. Physiol. (Lond.) | pmid:7990033 |
| Hara A et al. | Beneficial effects of dilazep on the palmitoyl-L-carnitine-induced derangements in isolated, perfused rat heart: comparison with tetrodotoxin. | 1997 | Jpn. J. Pharmacol. | pmid:9243322 |
| Matsui K et al. | Effect of l-carnitine chloride and its acetyl derivative on the electrophysiological derangement induced by palmityl-l-carnitine in isolated canine ventricular muscle. | 1985 | Jpn. J. Pharmacol. | pmid:4087570 |
| Brosnan JT and Reid K | Inhibition of palmitoylcarnitine oxidation by pyruvate in rat heart mitochondria. | 1985 | Metab. Clin. Exp. | pmid:3999980 |
| Privette JD et al. | Fatty acid oxidation by skeletal muscle homogenates from morbidly obese black and white American women. | 2003 | Metab. Clin. Exp. | pmid:12800100 |
| Shao Y et al. | Lipid metabolites and their differential pro-arrhythmic profiles: of importance in the development of a new anti-arrhythmic pharmacology. | 2014 | Mol. Cell. Biochem. | pmid:24771065 |